CCL2 and chronic kidney disease: While prior research in early-stage CKD demonstrated that serum MCP-1 was associated with albuminuria and eGFR in patients with preserved kidney [19], the prognostic utility of MCP-1 may be attenuated in populations with advanced CKD and high baseline MCP-1 levels.